SCHEMBL18050876

SCHEMBL18050876

NC(=O)c1ncn(Cc2ccc(C(F)(F)F)cc2)c1C(N)=O

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.51
ALDH1A1 P00352 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
PKM P14618 2/20 0.46
GAA P10253 1/20 0.46
TSHR P16473 1/20 0.46
SCD O00767 1/20 0.43
KMT2A Q03164 1/20 0.43
MAOB P27338 1/20 0.43
QPCT Q16769 2/20 0.42
NR3C1 P04150 3/20 0.41
QPCTL Q9NXS2 1/20 0.40
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
HIF1A Q16665 1/20 0.39
EPAS1 Q99814 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991370 0.86 KDM4E (0.51) KDM4EALDH1A1SMN1; SMN2PKMGAA
SCHEMBL18050897 0.85 PKM (0.49) SMN1; SMN2PKMGAATSHRSCD
SCHEMBL18050890 0.83 SCD (0.56) SMN1; SMN2PKMGAATSHRSCD
SCHEMBL11484432 0.82 PKM (0.69) KDM4EALDH1A1SMN1; SMN2PKMGAA
SCHEMBL18050874 0.82 SCD (0.49) ALDH1A1SMN1; SMN2PKMGAATSHR
SCHEMBL7984668 0.80 POLB (0.49) KDM4EALDH1A1SMN1; SMN2NR3C1HIF1A
SCHEMBL2145227 0.78 ADORA3 (0.51) KDM4EALDH1A1SMN1; SMN2KMT2ANR3C1
SCHEMBL18050879 0.78 NPC1 (0.47) ALDH1A1PKMGAATSHRSCD
SCHEMBL18050896 0.78 PKM (0.46) SMN1; SMN2PKMGAATSHRSCD
SCHEMBL20591092 0.78 KDM4E (0.47) KDM4EALDH1A1SMN1; SMN2PKMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106692138-B Application of N-benzyl imidazole amide derivative as polymyxin antibiotic synergist 广州英赛特生物技术有限公司 2020-08-04 CN disclosed
US-10435376-B2 Derivatives of 1H-imidazole-4,5-dicarboxamide and use thereof in preparation of anticoccidial drugs Guangzhou Insighter Biotechnology Co., Ltd. (CN) 2019-10-08 US disclosed
US-10435376-B2 Derivatives of 1H-imidazole-4,5-dicarboxamide and use thereof in preparation of anticoccidial drugs Guangzhou Insighter Biotechnology Co., Ltd. (CN) 2019-10-08 US disclosed
US-20180370921-A1 Derivatives of 1H-imidazole-4,5-dicarboxamide and Use Thereof in Preparation of Anticoccidial Drugs GUANGZHOU INSIGHTER BIOTECHNOLOGY CO.,LTD. (CN) 2018-12-27 US disclosed
WO-2017113525-A1 APPLICATION OF N-BENZYLIMIDAZOLECARBOXAMIDE DERIVATIVES AS SYNERGIST FOR POLYMYXIN ANTIBIOTICS 广州英赛特生物技术有限公司 2017-07-06 WO disclosed
WO-2016141736-A1 GLYCALPYRAMIDE DERIVATIVE AND APPLICATION THEREOF IN PREPARATION OF ANTICOCCIDIAL DRUG 广州英赛特生物技术有限公司 2016-09-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180370921-A1 Derivatives of 1H-imidazole-4,5-dicarboxamide and Use Thereof in Preparation of Anticoccidial Drugs CYP3A5, DDC, CPS1 KDM4E 63/4885ALDH1A1 450/4885SMN1; SMN2 4571/4885
US-10435376-B2 Derivatives of 1H-imidazole-4,5-dicarboxamide and use thereof in preparation of anticoccidial drugs CYP3A5, DDC, CPS1 KDM4E 63/4885ALDH1A1 450/4885SMN1; SMN2 4571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.